David Shen
Amministratore Delegato presso Proteologix US, Inc.
Profilo
David Wenyan Shen is currently the Chairman & Chief Executive Officer at Proteologix US, Inc. He previously held positions as the Executive Director-Biologics Research at GlycoFi, Inc., Merck, Inc., and NGM Biopharmaceuticals, Inc. He also served as the Vice President-Biologics at Teva Pharmaceuticals USA, Inc. Dr. Shen holds a doctorate degree from the University of Toronto and an undergraduate degree from East China University of Science & Technology.
Posizioni attive di David Shen
| Società | Posizione | Inizio |
|---|---|---|
Proteologix US, Inc.
 Proteologix US, Inc. BiotechnologyHealth Technology Proteologix US, Inc. is based in Redwood City, CA. Part of Johnson & Johnson, Proteologix US, Inc. is a biopharmaceutical company. The CEO of the company is David Wenyan Shen. Proteologix US was acquired by Johnson & Johnson on June 21, 2024 for $850 million. | Amministratore Delegato | - |
Precedenti posizioni note di David Shen
| Società | Posizione | Fine |
|---|---|---|
| NGM BIOPHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/07/2021 |
GlycoFi, Inc.
 GlycoFi, Inc. BiotechnologyHealth Technology GlycoFi, Inc. develops biopharmaceutical products. It provides protein production technology to develop, produce and commercialize biotherapeutics products. The company was founded by Tillman Gerngross in 2000 and is headquartered in Lebanon, NH. | Corporate Officer/Principal | - |
| Merck, Inc. | Corporate Officer/Principal | - |
Teva Pharmaceuticals USA, Inc.
 Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Teva Pharmaceuticals USA, Inc. engages in the manufacturing and marketing of generic pharmaceuticals. The firm also provides medical affairs, quality plus safety and trade partner services. The company was founded in 1985 and is headquartered in Parsippany, NJ. | Corporate Officer/Principal | - |
Formazione di David Shen
| East China University of Science & Technology | Undergraduate Degree |
| University of Toronto | Doctorate Degree |
Esperienze
Posizioni ricoperte
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| NGM BIOPHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 4 |
|---|---|
Teva Pharmaceuticals USA, Inc.
Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Teva Pharmaceuticals USA, Inc. engages in the manufacturing and marketing of generic pharmaceuticals. The firm also provides medical affairs, quality plus safety and trade partner services. The company was founded in 1985 and is headquartered in Parsippany, NJ. | Health Technology |
| Merck, Inc. | |
GlycoFi, Inc.
GlycoFi, Inc. BiotechnologyHealth Technology GlycoFi, Inc. develops biopharmaceutical products. It provides protein production technology to develop, produce and commercialize biotherapeutics products. The company was founded by Tillman Gerngross in 2000 and is headquartered in Lebanon, NH. | Health Technology |
Proteologix US, Inc.
Proteologix US, Inc. BiotechnologyHealth Technology Proteologix US, Inc. is based in Redwood City, CA. Part of Johnson & Johnson, Proteologix US, Inc. is a biopharmaceutical company. The CEO of the company is David Wenyan Shen. Proteologix US was acquired by Johnson & Johnson on June 21, 2024 for $850 million. | Health Technology |
- Borsa valori
- Insiders
- David Shen
